Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control

NCT02198027 is registered in ClinicalTrials.gov with Indus Hospital and Health Network as lead sponsor.

NCT NCT02198027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control
Lead sponsor
Indus Hospital and Health Network
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2014
Completion date
December 31, 2014
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain